Curcumin and curcumin-loaded poly(caprolactone) nanoparticles restore mitochondrial function in an in vitro Parkinson’s disease model

dc.contributor.authorDube, Admire
dc.contributor.authorBuck, Amy Claire
dc.contributor.authorSmith, Liezel
dc.date.accessioned2026-09-22T06:20:17Z
dc.date.available2026-09-22T06:20:17Z
dc.date.issued2025
dc.description.abstractBackground: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor symptoms resulting from the selective loss of dopaminergic neurons in the substantia nigra. Mitochondrial dysfunction is a key mechanism in idiopathic and familial PD, yet the cause is poorly understood. Paraquat (PQ) induces mitochondrial dysfunction, though its effect remains uncertain. Curcumin, a phytochemical with antioxidant, antiinflammatory, and neuroprotective properties, shows therapeutic promise for PD but has unfavorable pharmacokinetics. Nanoparticles (NPs) offer a solution by improving curcumin’s stability, bioavailability, and in providing targeted delivery. Purpose: To examine mitochondrial bioenergetics in a PQ-induced PD in vitro model and evaluate the potential of curcumin-loaded polymeric nanoparticles (CNPs) to rescue mitochondrial function. Methods: CNPs were synthesized and characterized to explore therapeutic suitability. Using the Oroboros system, mitochondrial respiration was assessed in SH-SY5Y cells treated with PQ, curcumin, CNPs, and their respective pre- and post-PQ treatment regimens. Furthermore, mitochondrial morphology was assessed. Results: PQ caused a significant decrease in complex I-linked oxidative phosphorylation and the electron transfer system capacity. CNP pre- and post-PQ treatments reduced PQ-induced structural mitochondrial damage. For post-PQ treatment, CNP improved complex IV activity, while curcumin recovered PQ’s effect on N- and Gppathway activity. CNP pre-PQ treatment enhanced pyruvate-linked respiration and reduced ROX levels. Notably, curcumin pre-PQ treatment had the strongest protective effect, restoring multiple respiratory parameters. Conclusion: The findings from this study suggest that curcumin and CNPs have potential in protecting PQ-induced reduction of respiratory states and rates in mitochondria. The findings lay a foundation for optimizing curcumin delivery using NPs for potential therapeutic applications in PD.
dc.identifier.citationBuck, A.C., Smith, L., Dube, A., Bardien, S. and Maarman, G.J., 2025. Curcumin and Curcumin-loaded poly (caprolactone) nanoparticles restore mitochondrial function in an in vitro Parkinson’s disease model. Phytomedicine Plus, p.100893.
dc.identifier.urihttps://doi.org/10.1016/j.phyplu.2025.100893
dc.identifier.urihttps://hdl.handle.net/10566/25480
dc.language.isoen
dc.publisherElsevier B.V.
dc.subjectCurcumin
dc.subjectCurcumin-loaded nanoparticles
dc.subjectMitochondria
dc.subjectMitochondrial dysfunction
dc.subjectParkinson’s disease
dc.titleCurcumin and curcumin-loaded poly(caprolactone) nanoparticles restore mitochondrial function in an in vitro Parkinson’s disease model
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
dube_curcumin_and_curcumin_loaded_2025.pdf
Size:
3.7 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: